Vivos Therapeutics (VVOS) EBITDA Margin Growth (1y) (2021 - 2026)
Vivos Therapeutics (VVOS) EBITDA Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -430.00 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 128.00 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -361.00 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 102.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 58.00 |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 851.00 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -313.00 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 535.00 |
| 10 | Vivos Therapeutics | 7.39 Mn | 5.16 Mn | 3.06 Mn | 44.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44.00 |
| Dec 31, 2025 | -9,895.00 |
| Sep 30, 2025 | 204.00 |
| Jun 30, 2025 | -7,421.00 |
| Mar 31, 2025 | -1,550.00 |
| Dec 31, 2024 | 4,792.00 |
| Sep 30, 2024 | 4,131.00 |
| Jun 30, 2024 | 8,481.00 |
| Mar 31, 2024 | 1,680.00 |
| Dec 31, 2023 | 2,481.00 |
| Sep 30, 2023 | 1,539.00 |
| Jun 30, 2023 | 3,156.00 |
| Mar 31, 2023 | 5,212.00 |
| Dec 31, 2022 | -34,640.00 |
| Sep 30, 2022 | -378.00 |
| Jun 30, 2022 | -7,315.00 |
| Mar 31, 2022 | -8,082.00 |
| Dec 31, 2021 | 10,158.00 |
| Sep 30, 2021 | -6,857.00 |
| Jun 30, 2021 | -4,750.00 |